NAUT
Nautilus Biotechnology, Inc.
1.96$
+24.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | 100.0% | 100.0% | |
| – | 19.4% | – | – | – | 66.2% | – | – | – | – | – | -593.2% | 1,871.6% | |
| – | -19.4% | – | – | – | -66.2% | – | – | – | – | – | 693.2% | -1,771.6% | |
| – | 145.0% | – | – | – | 113.0% | – | – | – | – | – | 5,059.5% | 20,796.8% | |
| – | 91.8% | – | – | – | 74.6% | – | – | – | – | – | 3,328.9% | 12,872.6% | |
| – | 224.2% | – | – | – | 141.9% | – | – | – | – | – | 8,989.5% | 32,124.2% | |
| – | -243.6% | – | – | – | -208.1% | – | – | – | – | – | -8,296.3% | -33,043.7% | |
| – | 37.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -207.3% | – | – | – | -183.3% | – | – | – | – | – | -7,615.3% | -29,747.9% | |
| – | -36.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -207.3% | – | – | – | -183.3% | – | – | – | – | – | -7,615.3% | -29,747.9% | |
| – | -187.9% | – | – | – | -117.1% | – | – | – | – | – | -8,296.3% | -28,960.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.